Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Suv39h2em1/Cya
Common Name:
Suv39h2-KO
Product ID:
S-KO-11446
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Suv39h2-KO
Strain ID
KOCMP-64707-Suv39h2-B6J-VA
Gene Name
Suv39h2
Product ID
S-KO-11446
Gene Alias
4930507K23Rik; D030054H19Rik; D2Ertd544e; KMT1B
Background
C57BL/6JCya
NCBI ID
64707
Modification
Conventional knockout
Chromosome
2
Phenotype
MGI:1890396
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Suv39h2em1/Cya mice (Catalog S-KO-11446) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000027956
NCBI RefSeq
NM_022724
Target Region
Exon 2
Size of Effective Region
~1.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
SUV39H2, also known as KMT1B, is a member of the SUV39 subfamily of lysine methyltransferases. It plays a significant role in histone H3-K9 di-/tri-methylation, transcriptional regulation, and cell cycle. Its activities are crucial for maintaining heterochromatin and gene repression, and it is involved in various biological processes [2,6].

In degenerated nucleus pulposus cells, SUV39H2-mediated K141 mono-methylation of PPP1CA disrupts TFEB-dependent autophagy, promoting intervertebral disc degeneration [1]. In trophoblast stem cells, SUV39H2 contributes to cell maintenance and restrains differentiation, and its disruption leads to cell proliferation arrest and differentiation activation [3]. In cardiomyocytes, knockdown of SUV39H2 accelerates senescence, while overexpression inhibits this phenotype, protecting cardiomyocytes from oxidative stress-induced damage through the p53-BTG2 pathway [4]. In gastric cancer, SUV39H2 promotes proliferation, inhibits apoptosis, and reduces chemosensitivity by promoting homologous recombination through epigenetic repression of DUSP6 [5]. In epidermal stem and progenitor cells, loss of SUV39H2 function relieves gene repression, enhancing Wnt activity and causing premature cell cycle exit [7]. Ablation of SUV39H2 in hepatocytes attenuates non-alcoholic steatohepatitis (NASH) in mice by regulating Vanin-1 transcription [8]. In osteosarcoma cells, knockdown of SUV39H2 suppresses cancer cell growth, viability, and induces apoptosis [9].

In summary, SUV39H2 is essential for multiple biological processes and is involved in various disease conditions. Through gene-knockout or conditional-knockout mouse models and other loss-of-function experiments, we have learned that SUV39H2 is implicated in diseases such as intervertebral disc degeneration, NASH, and several types of cancer, highlighting its potential as a therapeutic target in these disease areas.

References:

1. Liang, Huaizhen, Luo, Rongjin, Li, Gaocai, Song, Yu, Yang, Cao. 2023. Lysine methylation of PPP1CA by the methyltransferase SUV39H2 disrupts TFEB-dependent autophagy and promotes intervertebral disc degeneration. In Cell death and differentiation, 30, 2135-2150. doi:10.1038/s41418-023-01210-4. https://pubmed.ncbi.nlm.nih.gov/37605006/

2. Li, Baihui, Zheng, Yu, Yang, Lili. 2019. The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View. In Journal of Cancer, 10, 721-729. doi:10.7150/jca.28254. https://pubmed.ncbi.nlm.nih.gov/30719171/

3. Wang, Lei, Chakraborty, Damayanti, Iqbal, Khursheed, Soares, Michael J. 2021. SUV39H2 controls trophoblast stem cell fate. In Biochimica et biophysica acta. General subjects, 1865, 129867. doi:10.1016/j.bbagen.2021.129867. https://pubmed.ncbi.nlm.nih.gov/33556426/

4. Wang, Kan, Zhu, Qiang Zhang, Ma, Xian Tao, Cheng, Cai. 2021. SUV39H2/KMT1B Inhibits the cardiomyocyte senescence phenotype by down-regulating BTG2/PC3. In Aging, 13, 22444-22458. doi:10.18632/aging.203551. https://pubmed.ncbi.nlm.nih.gov/34559682/

5. Yang, Jing, Xu, Penghui, Chen, Zetian, Li, Bowen, Xu, Zekuan. 2023. N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer. In Cancer letters, 558, 216092. doi:10.1016/j.canlet.2023.216092. https://pubmed.ncbi.nlm.nih.gov/36806557/

6. Weirich, Sara, Khella, Mina S, Jeltsch, Albert. 2021. Structure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases. In Life (Basel, Switzerland), 11, . doi:10.3390/life11070703. https://pubmed.ncbi.nlm.nih.gov/34357075/

7. Balmer, Pierre, Hariton, William V J, Sayar, Beyza S, Roosje, Petra, Müller, Eliane J. . SUV39H2 epigenetic silencing controls fate conversion of epidermal stem and progenitor cells. In The Journal of cell biology, 220, . doi:10.1083/jcb.201908178. https://pubmed.ncbi.nlm.nih.gov/33604655/

8. Wu, Shiqiang, Ren, Wenjing, Hong, Jiameng, Yang, Yuyu, Lu, Yunjie. 2024. Ablation of histone methyltransferase Suv39h2 in hepatocytes attenuates NASH in mice. In Life sciences, 343, 122524. doi:10.1016/j.lfs.2024.122524. https://pubmed.ncbi.nlm.nih.gov/38401627/

9. Piao, Lianhua, Yuan, Xiaofeng, Zhuang, Ming, Kong, Ren, Liu, Zhiwei. 2018. Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma. In Oncology reports, 41, 325-332. doi:10.3892/or.2018.6843. https://pubmed.ncbi.nlm.nih.gov/30542727/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest